Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
暂无分享,去创建一个
Nagara Tamaki | Toshiki Takei | Kunihiro Nakada | Yuji Kuge | Takafumi Mochizuki | N. Tamaki | Songji Zhao | Y. Kuge | K. Nakada | Songji Zhao | Toshiki Takei | Toshiyuki Takahashi | Masayuki Sato | T. Mochizuki | Toshiyuki Takahashi | Masayuki Sato
[1] G. Semenza,et al. Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.
[2] G. Glatting,et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Y. Nishimura,et al. Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] N. Tamaki,et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions , 2001, European Journal of Nuclear Medicine.
[5] R L Wahl,et al. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] T. Saga,et al. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] R L Wahl,et al. An Immunohistochemical Study , 2006 .
[8] M. Birnbaum,et al. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. , 1987, Science.
[9] T. Ido,et al. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] W. Chapman,et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] N. Tamaki,et al. Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading , 2002, Nuclear medicine communications.
[12] Cyrill Burger,et al. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] R L Wahl,et al. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] R Iwata,et al. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] Paul J. van Diest,et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .
[16] N. Tamaki,et al. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] H. Yagata,et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose , 1998, Cancer.
[18] G. van Kaick,et al. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. , 1994, Nuclear medicine and biology.
[19] W C Eckelman,et al. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. , 1999, Cancer research.
[20] T. A. Smith,et al. Mammalian hexokinases and their abnormal expression in cancer. , 2000, British journal of biomedical science.
[21] G. Semenza,et al. Levels of Hypoxia-Inducible Factor-1α During Breast Carcinogenesis , 2001 .
[22] Mark A. Stephenson,et al. Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival , 1997, Cancer.
[23] R. Wahl,et al. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] N. Tamaki,et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] T. Ido,et al. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] S. Bessman,et al. Hexokinase Binding to Mitochondria: A Basis for Proliferative Energy Metabolism , 1997, Journal of bioenergetics and biomembranes.
[27] D A Hilton,et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.
[28] G. Lucignani,et al. The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[29] Julie Sutcliffe-Goulden,et al. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] T. Suzuki,et al. Enhanced expression of glucose transporter GLUT3 in tumorigenic HeLa cell hybrids associated with tumor suppressor dysfunction. , 1999, European journal of biochemistry.
[31] J. Nährig,et al. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] D. Jewett,et al. Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. , 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[33] Jeih-San Liow,et al. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] G I Bell,et al. Structure and function of mammalian facilitative sugar transporters. , 1993, The Journal of biological chemistry.
[35] R. Iwata,et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] H. Lodish,et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.
[37] T Ido,et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] I. Whittle,et al. The development of necrosis and apoptosis in glioma: experimental findings using spheroid culture systems* , 2001, Neuropathology and applied neurobiology.
[39] R L Wahl,et al. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.